BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28847289)

  • 1. Fate of T Cells and their Secretory Proteins During the Progression of Leprosy.
    Tarique M; Saini C; Naz H; Naqvi RA; Khan FI; Sharma A
    Curr Protein Pept Sci; 2018; 19(9):889-899. PubMed ID: 28847289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
    Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
    Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T helper cells in leprosy: An update.
    Saini C; Tarique M; Rai R; Siddiqui A; Khanna N; Sharma A
    Immunol Lett; 2017 Apr; 184():61-66. PubMed ID: 28235552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events.
    Azevedo MCS; Marques H; Binelli LS; Malange MSV; Devides AC; Silva EA; Fachin LRV; Ghidella CC; Soares CT; Garlet GP; Rosa PS; Belone AFF; Trombone APF
    Med Microbiol Immunol; 2017 Dec; 206(6):429-439. PubMed ID: 28875310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Concepts of Adaptive Immunity in Leprosy.
    Sadhu S; Mitra DK
    Front Immunol; 2018; 9():604. PubMed ID: 29686668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T regulatory cells and plasmocytoid dentritic cells in hansen disease: a new insight into pathogenesis?
    Massone C; Nunzi E; Ribeiro-Rodrigues R; Talhari C; Talhari S; Schettini APM; Parente JNT; Brunasso AM; Puntoni M; Clapasson A; Noto S; Cerroni L
    Am J Dermatopathol; 2010 May; 32(3):251-256. PubMed ID: 20075708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell regulation in lepromatous leprosy.
    Bobosha K; Wilson L; van Meijgaarden KE; Bekele Y; Zewdie M; van der Ploeg-van Schip JJ; Abebe M; Hussein J; Khadge S; Neupane KD; Hagge DA; Jordanova ES; Aseffa A; Ottenhoff TH; Geluk A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2773. PubMed ID: 24722473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of interleukin-2 on proliferative responses of peripheral blood T cells from leprosy patients.
    Choi IH; Shin JS; Kim JD; Kim SJ
    Yonsei Med J; 1991 Sep; 32(3):237-42. PubMed ID: 1781183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th9 cytokines response and its possible implications in the immunopathogenesis of leprosy.
    de Sousa JR; Pagliari C; de Almeida DSM; Barros LFL; Carneiro FRO; Dias LB; de Souza Aarão TL; Quaresma JAS
    J Clin Pathol; 2017 Jun; 70(6):521-527. PubMed ID: 27927694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.